YOLFTbeta
DRTECH Corporation

DRTECH Corporation

214680 · KQ · Healthcare / Medical Devices

3,960.00KRW+325.00 (+8.94%)

Price History

Full chart

Market Stats

Previous Close3,635.00
Open3,785.00
Day Range3,620.00 – 4,000.00
52-Week Range3,405.00 – 11,825.00
Volume76.24K
Market Cap64.78B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta0.20
50-Day Avg4,391.80
200-Day Avg7,374.40

About

DRTECH Corporation develops and sells flat-panel X-ray detectors for digital radiography in South Korea and internationally. Its products include detectors for general radiography, mammography, dynamic, dental, veterinary, and industrial applications; imaging solutions, including specialized UI software, dual energy x-ray imaging, AI imaging processing, advanced image reconstruction technology, and AI CAD; and radiography, mammography, and C-arm systems. DRTECH Corporation was founded in 2000 and is headquartered in Seongnam-si, South Korea.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Seong-Hyun An
  • Employees363
  • HeadquartersSPG Dream building, Seongnam-si, South Korea, 13558, Korea
  • Websitehttps://www.drtech.co.kr

Leadership

  • Mr. Seong-Hyun AnCEO & Executive Director · b. 1963
  • Mr. Kilsoo LeeCFO, Head of Corporate Planning & Executive Director · b. 1965
  • Mr. Cheol-woo ShinCOO, Head of Medical Business Development Division & Executive Director · b. 1968
  • Mr. Soo Chul ParkSenior EVP, Head of Global Sales Division & Executive Director · b. 1960
  • Mr. Beomjin MoonSenior Executive VP, Head of New Business Development Division & Executive Director · b. 1965

Financials

Income Statement

Currency: KRW2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-36.64B38.80B44.71B47.85B55.27B70.28B89.48B92.44B97.56B116.30B
Growth (%)--+5.91%+15.23%+7.00%+15.52%+27.16%+27.33%+3.31%+5.54%+19.21%
Cost of Revenue-19.19B22.88B24.73B25.92B33.85B38.40B49.18B50.09B58.05B74.32B
Gross Profit-17.45B15.93B19.99B21.93B21.42B31.87B40.31B42.35B39.51B41.98B
Gross Margin-47.61%41.05%44.70%45.83%38.76%45.36%45.04%45.81%40.50%36.10%
Operating Expense-15.03B16.99B18.42B20.89B27.01B29.08B35.39B42.24B51.62B55.87B
Operating Income-30.26M2.42B-1.06B1.56B1.04B-5.58B2.80B4.92B109.37M-12.11B-13.89B
Operating Margin-6.59%-2.73%3.50%2.16%-10.10%3.98%5.49%0.12%-12.41%-11.95%
EBITDA-------13.09B9.10B-4.39B-6.64B
EBITDA Margin-------14.63%9.85%-4.50%-5.71%
Net Income48.21M-435.44M-1.81B1.25B944.61M-7.23B4.04B5.97B-2.25B-19.29B-24.03B
Net Income Margin--1.19%-4.68%2.79%1.97%-13.08%5.75%6.67%-2.43%-19.77%-20.66%
R&D-4.81B5.38B6.13B-9.24B11.02B10.82B11.52B16.85B16.16B
R&D as % of Total Revenue-13.12%13.86%13.71%-16.71%15.67%12.09%12.46%17.28%13.89%
Interest Expense00000546.54M541.22M1.36B1.98B4.40B7.99B
Interest Expense % of Total Revenue-0.00%0.00%0.00%0.00%0.99%0.77%1.52%2.14%4.51%6.87%

Balance Sheet

Currency: KRW2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets37.62B43.51B49.80B70.96B91.81B93.90B120.78B164.02B179.35B201.88B
Total Liabilities10.32B17.01B18.47B33.60B58.71B49.78B60.40B79.42B106.57B125.11B
Total Equity27.30B26.50B31.33B37.36B33.10B44.11B60.38B84.57B72.77B76.74B
Cash961.89M1.55B1.79B13.60B15.65B10.29M7.90M12.17B14.31M21.18B
Total Debt-11.56B-21.15B34.49B-----
Net Debt----24.95B21.67B18.31B19.69B38.02B45.06B

Cash Flow

Currency: KRW2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-25.17M-7.16B-2.84B2.98B3.60B-1.57B-1.01B5.04B-7.94B-16.03B-20.13B
Investing Cash Flow-8.87B6.39B-3.78B-4.35B-3.88B-14.12B-642.90M-11.90B-15.48B-5.70B-
Financing Cash Flow9.54B657.72M7.25B1.57B12.13B18.58B-3.37B10.10B21.86B23.75B-
Capital Expenditure02.50B2.46B2.94B3.18B6.39B4.49B7.13B9.96B9.66B6.77B
Free Cash Flow------8.13B-5.56B-2.76B-17.89B-25.68B-26.90B
Dividends Paid--------500.00K500.00K-
FCF to OCF-----516.58%550.79%-54.76%225.46%160.28%133.61%
Dividend Paid to FCF---------0.00%-0.00%-

Earnings

Report DateJun 30, 2015Sep 30, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Mar 31, 2017May 15, 2017Aug 23, 2017Nov 16, 2017Feb 5, 2018May 15, 2018Aug 14, 2018Nov 13, 2018Feb 12, 2019May 15, 2019Aug 14, 2019Nov 14, 2019Mar 20, 2020May 13, 2020Aug 14, 2020Nov 13, 2020Mar 5, 2021Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate--------------------------------------------
EPS Actual-15.72-18.4418.47-75.20-13.86-9.192.419.00-16.19-40.877.479.007.001.3710.841.7814.00-3.4520.00-22.00-17.00-111.7979.60280.66150.98-238.30114.58270.00300.00-343.86271.35-25.0025.00-316.12-1105.02-383.07-304.69-345.28-302.77-400.00185.80-971.47-53.0098.89
Surprise--------------------------------------------
Timing-----After-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market----------------------

Key Statistics & Ratios

Market Cap64.78B
Enterprise Value116.84B
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.51
Price / Book0.76
Revenue (TTM)126.23B
Gross Profit (TTM)50.06B
EBITDA1.20B
Profit Margin-9.93%
Operating Margin5.04%
Return on Equity-16.36%
Return on Assets-2.92%
Shares Outstanding16.70M
Shares Float13.12M
Beta0.20
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Sep 10, 20261:5